Literature DB >> 1597521

Detection of bone marrow metastases in neuroblastoma using a short term tissue culture technique.

J A Adams1, A M Kelsey, T F Carr, R F Stevens, P Morris-Jones.   

Abstract

AIMS: To improve detection of neuroblastoma metastases in the bone marrow: morphological evaluation of bone marrow is a routine and important component of the clinical staging of neuroblastoma and it depends on the successful identification of tumour cells which may only be present at extremely low levels.
METHODS: Bone marrow mononuclear cells from patients with neuroblastoma were incubated in a simple suspension culture and examined regularly using an inverted objective microscope. In some cases cytospins of the cultured cells were examined further using morphological and immunocytological techniques.
RESULTS: In some cultures spheroidal clumps of cells could be seen growing after only a few days. If the marrow was cultured for a longer period these spheroids continued to increase in size, became adherent to the stromal cell layer on the culture flask floor, and put out long characteristic processes (neurites). Morphological and immunocytological examination of cytospins from these cultures confirmed these cells as neuroblasts.
CONCLUSIONS: This method has provided the sole evidence of marrow metastases in several newly diagnosed cases of neuroblastoma in which the bone marrow had shown no evidence of tumour using standard morphological and fluorescent immunocytological techniques. Although negative cultures do not preclude the presence of neuroblastoma, this method is a useful adjunct to the standard techniques.

Entities:  

Mesh:

Year:  1992        PMID: 1597521      PMCID: PMC495306          DOI: 10.1136/jcp.45.5.424

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Immunohistochemical demonstration of neurone specific enolase in bone marrow infiltrated by neuroblastoma.

Authors:  J M Caillaud; F Martinez-Madrigal; O Hartmann; C Carlu
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

2.  International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Authors:  G M Brodeur; R C Seeger; A Barrett; F Berthold; R P Castleberry; G D'Angio; B De Bernardi; A E Evans; M Favrot; A I Freeman
Journal:  J Clin Oncol       Date:  1988-12       Impact factor: 44.544

3.  Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.

Authors:  M M Reid; J P Wallis; A G McGuckin; A D Pearson; A J Malcolm
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

4.  Levels of detection of tumor cells in human bone marrow with or without prior culture.

Authors:  S S Joshi; D J Novak; L Messbarger; V Maitreyan; D D Weisenburger; J G Sharp
Journal:  Bone Marrow Transplant       Date:  1990-09       Impact factor: 5.483

5.  Immunocytochemical examination of bone marrow in disseminated neuroblastoma.

Authors:  P J Carey; L Thomas; G Buckle; M M Reid
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

6.  Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies.

Authors:  I M Franklin; J Pritchard
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

7.  Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.

Authors:  T J Moss; C P Reynolds; H N Sather; S G Romansky; G D Hammond; R C Seeger
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

8.  Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

Authors:  D W Rogers; J G Treleaven; J T Kemshead; J Pritchard
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

9.  Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.

Authors:  M C Favrot; D Frappaz; O Maritaz; I Philip; B Fontaniere; O Gentilhomme; C Bailly; J M Zucker; J C Gentet; J Kemshead
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.